Abstract
Fournier's gangrene (FG) is a rare form of necrotizing soft tissue infection characterized by an acute, aggressive, and rapidly progressive course. In this case report, we describe advanced therapy combining critical care, surgery, pharmacotherapy, extended biochemical/cellular blood diagnostics, and post-discharge hyperbaric oxygen therapy rehabilitation. Such an intervention resulted in survival and improved health status and quality of life of the patient with FG and septic shock.
Keywords: fournier's gangrene, rehabilitation, necrotizing soft tissue infection (nsti), hyperbaric oxygen therapy (hbot), sepsis
Introduction
Fournier's gangrene (FG), a rare, life-threatening necrotizing infection affecting the perineum, perineal region, and genitals, is frequently misdiagnosed because of the nonspecific nature of its symptoms. In the absence of prompt and adequate treatment, FG can spread rapidly along the fascia plane, eventually leading to septic shock in a short time [1]. Despite advances made in comprehension of its pathophysiology, the associated mortality rate (from 20% to 88%) does not appear to have reduced over the past 25 years [2]. The complex and destructive nature of FG implicates multidisciplinary therapeutic approaches which evolve gradually. The timing, importance, extent, and details of the applied procedures are still a matter of controversy and discussion [3,4].
Moreover, the successful in-hospital stabilization of a patient’s condition does not guarantee full recovery. Even those who survive often necessitate multiple reconstructive surgeries, which may present a risk to immunocompromised sepsis survivors who are unable to accept skin grafts and suffer from poor wound healing [5].
Here, we present a case report of a patient who survived and finally recovered from FG and septic shock due to the timely and synergistic action of critical care support, surgery, antibiotics, blood purification, and bimodal (“acute” and “chronic”) hyperbaric oxygenation, supported by extended biochemical/cellular blood diagnostics.
Case presentation
A previously healthy 52-year-old man was admitted to the hospital in general critical condition after cardiac arrest and with rapidly progressing necrotizing soft tissue infection (NSTI) of his buttocks and perineum. On the same day, FG was diagnosed. The patient’s NSTI continued to advance and was accompanied by septic shock. Tissue cultures demonstrated a polymicrobial infection; therefore, treatment consisted of broad-spectrum antibiotics (BSAs) (Figure 1).
Fluid resuscitation, urine output monitoring, and four days of hemoadsorption using the extracorporeal adsorption device (CytoSorb, https://cytosorb-therapy.com/) were also implemented. Additionally, the patient underwent bilateral orchiectomy and colostomy, and he was aggressively treated with daily or alternating-day operative debridement of the necrotic tissues regarding the entire perineum, inguinal regions, bilateral thighs, buttocks, and circumferential abdominal wall. At the same time, he started emergency hyperbaric oxygen therapy (HBOT) sessions lasting 90 minutes at 2.5 atm - three sessions within 24 hours from admission, four sessions within 72 hours, and 11 subsequent sessions once a day. After seven days, the patient’s condition improved, and he was extubated. However, due to a high risk of fecal contamination, infected anal sphincter, and large perianal defects, a colostomy was performed. After that, the patient’s condition worsened, and he went into acute respiratory failure. X-ray examination revealed pulmonary lesions that were consistent with bilateral interstitial pneumonia. The patient was intubated again, and nebulized colistin therapy was administrated. After the next six days, the patient’s condition improved, and sedation was discontinued (Figure 2).
From the day of patient admission, detailed microscopic examinations of blood smears and live-cell imaging of leukocyte activity were periodically performed during the entire hospitalization. The observations showed characteristic blood cell morphological changes, which correlated with the selected results of routine laboratory tests and the patient’s general condition. As the indications, we marked characteristic blood changes with red flags (during the patient’s critical state), yellow (as a reflection of the serious but stable general condition of the patient), and green flags (during the patient’s condition improvement phase) (Figure 3), (Table 1).
Table 1. Median and standard deviation (mean±STD) of selected blood test results which correlate with the characteristic blood cell morphological changes and patient’s general condition.
Test | Reference range | Red flags (patient’s critical state) | Yellow flags (serious but stable general condition of the patient) | Green flags (patient’s condition improvement phase) |
White blood cell count | 4-10 x 103/μL | 18.6±4.9 | 14.3±0.36 | 10.7±1.78 |
Neutrophils | 1.6-7 x 103/μl | 12.52±0.9 | 8.7±0.8 | 4.43±0.3 |
Lymphocytes | 0.8-4.5 x 103/μl | 1.42±0.26 | 2.63±0.5 | 3.78±0.31 |
Monocytes | 0.2-1.2 x 103/μl | 0.59±0.06 | 0.65±0.02 | 1.67±0.2 |
Immature granulocyte count | 0-0.03 x 10^3/μl | 2.45±0.24 | 0.7±0.11 | 0.05±0.01 |
Erythrocytes | 3.5-5.2 x 10^6/μL | 2.6±0.15 | 3.44±0.09 | 4.31±0.25 |
Hemoglobin | 11-15 g/dL | 8.06±0.17 | 11.06±0.62 | 12.6±0.9 |
Hematocrit | 34-45% | 22.8±1.42 | 32.3±1.2 | 39.2±2.3 |
Platelets | 150-400 x 10^3/μl | 53.5±11.5 | 183.5±36.6 | 369.3±61.4 |
Fibrinogen | 2-4 g/L | 9.38±1.2 | 6.3±0.7 | 4.4±0.9 |
D-dimer | <500 ng/mL | 13551±813.7 | 4748.8±674.7 | 1257.5±341.3 |
Procalcitonin | <0.5 ng/mL | 70.4±33.4 | 1.93±0.06 | 0.09±0.04 |
C-reactive protein | <0.5 mg/L | 367.2±75.4 | 110.4±25.3 | 27.2±21.4 |
Creatinine | 58-96 μmol/L | 39.5±3.2 | 50.3±2.5 | 68.5±4.03 |
Just after hospital discharge, the patient started the experimental three-month diagnostically monitored rehabilitation program in the form of modified HBOT (three times a week, 36 sessions of breathing 100% oxygen at 2.5 atm for 90 minutes). According to the RehaSep trial protocol, a wide range of physiological, hematological (Figure 3M-3P), and biochemical (blood tests) parameters were assessed at hospital discharge and during the subsequent three months in order to monitor changes in physical capacity, immunity, and degree of post-sepsis organ damage/recovery [6]. The patient, discharged immobile in a wheelchair, progressively regained walking ability within a three-month HBOT rehabilitation period. The total work ((kJ) measured by a cycloergometer) achieved by the patient in the ECG exercise test at the beginning and end of rehabilitation increased by 195% (from 20 to 59 kJ). In the quality of life assessment using the “Life after sepsis survey,” the patient reported that the majority of the assessed physiologic and functional capacities were significantly improved (Figure 2C) [7].
Discussion
FG is a special form of NSTI characterized by an acute, aggressive, and rapidly progressive course [8]. During the development of NSTI, the microbial virulence caused by the toxins produced via the involved bacteria outweighs the host defense system, thus, promoting the rapid spreading of the infection and fulminant tissue destruction [9]. Concomitantly, this carries a substantial risk of the dysregulated host response to infection that can lead to sepsis and sepsis-associated multi-organ failure [10]. During sepsis, there is a full-blown, systemic activation of immune responses due to the massive release of pathogen- and damage-associated molecular patterns (PAMP, DAMP) from invading microorganisms and/or damaged host tissues, which leads to the overstimulation of immune cells, eventually resulting in immunosuppression. Moreover, sepsis is accompanied by a markedly imbalanced cytokine response (“cytokine storm”) that converts responses that are normally beneficial in the case of fighting infections into excessive, damaging inflammation [10]. Therefore, early resection of necrotic and infected tissues and appropriate BSA therapy are cornerstones of NSTI management [8]. Therefore, the immune system supported by BSAs has better odds of controlling the infection. In several studies, it was found that early surgical treatment reduces not only the mortality rate but also the risk of septic shock and the length of hospital stay [9,11-13]. However, there is still no consensus concerning a potential cut-off point for the “golden time-frame” in which the initial surgery should be performed [9].
It has been proved that the complete blood cell count (CBC) with differentials may contain a considerable amount of information, often providing early clues to the diagnosis of sepsis. Nonetheless, emerging evidence allows to suggest that emphasis should be shifted toward the neutrophil-to-lymphocyte ratio and, perhaps, the fraction of immature granulocytes emerging about one day after clinical infection [14]. Therefore, not only the CBC test and clinical condition of the patient but also microscopic observation of leukocyte activity as well as blood plasma features should determine the course of therapeutic actions.
Based on our observations, the increased number of blood microparticles is the main visible sign of the PAMP/DAMP release leading to a reduction in spontaneous leukocyte activity that accompanies the deterioration of a patient's condition. Our observations suggest that assessing the individual trajectory of the patient's leukocyte activation, functions, and interactions may prove crucial in deepening our understanding of this complex disease process, as immune cells are engaged from the very beginning to the very end - their composition, behavior, and secretions are indices of FG/sepsis dynamics. We are convinced that intensive efforts should be made to further develop cell analysis methods better applicable in medical diagnostics, providing the key to novel and effective therapies.
During sepsis, oxygen consumption at the cellular and mitochondrial levels is drastically impaired [15]. On the other hand, severe wounds and tissue damages are characteristic of FG and other NSTIs. Hence, HBOT with its immunostimulatory, angiogenic, and antimicrobial effects is now frequently used as adjunctive critical care treatment [16,17].
Yet, in this case (besides the critical care phase), we have applied HBOT as the rehabilitation treatment for an FG/sepsis survivor for the first time. Our experimental therapy was accompanied by extensive biochemical and microscopic monitoring to secure the patient’s safety. This attempt proved safe, successful, and measurably effective.
Conclusions
NSTI with septic shock is a very serious and complex medical condition that should be under the care of an interdisciplinary team with access not only to the best surgical and critical care but also to sepsis experts who can help find the best way and time for appropriate treatment. Additionally, in contrast to the present fragmented primary care-based scheme, the continuity of integrated and coordinated care after hospital discharge is essential in the improvement of patient health and well-being, which defines a long-awaited successful management of FG.
HBOT could be recommended as a new opportunity for therapy continuation, especially among patients with contraindications to exercise training (e.g., unhealed wounds) within the key “therapeutic window” for rehabilitation just after hospital discharge. Nonetheless, in our opinion (based on our growing post-sepsis therapy experience), the HBOT rehabilitation sessions should be scheduled on alternate days in order to offset the transient effects of oxidative stress, thus, improving treatment tolerance and patient safety. In addition, considering the same number of sessions prescribed, the therapy is prolonged (in comparison to the conventional daily schedule), letting more time for wounds/transplants to heal completely.
Acknowledgments
Special thanks should be given to Dr. Wojciech Mudyna, chief of the anesthesiology and intensive therapy department at Ludwik Rydygier Memorial Hospital in Krakow, and the whole ICU team who made a crucial contribution to this case report.
The authors have declared financial relationships, which are detailed in the next section.
Barbara Wójcik, Jerzy Superata, and Zbigniew Szyguła declare(s) a grant from National Science Centre. The research was funded by the National Science Centre, Krakow, Poland (Grant no. 2015/19/B/NZ7/03730). The funding source had no involvement in the study design, data processing, or writing.
Human Ethics
Consent was obtained or waived by all participants in this study. Local Bioethics Committee at the Regional Medical Chamber issued approval 136/KBL/OIL/ 2015. The protocol of the study was approved by the Local Bioethics Committee at the Regional Medical Chamber in Krakow, Poland. The research was performed according to the Declaration of Helsinki of 1964, as revised in 2013. The Patient gave consent for this case to be published
References
- 1.How likely is septic shock to develop in a patient with Fournier's gangrene? A risk prediction model based on a 7-year retrospective study. Yang Y, Wang LC, Yu XY, et al. Gastroenterol Rep. 2022;10:0. doi: 10.1093/gastro/goac038. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Mortality associated with Fournier's gangrene remains unchanged over 25 years. Radcliffe RS, Khan MA. BJU Int. 2020;125:610–616. doi: 10.1111/bju.14998. [DOI] [PubMed] [Google Scholar]
- 3.Desperate need for better management of Fournier's gangrene. Kranz J, Schlager D, Anheuser P, et al. Cent European J Urol. 2018;71:360–365. doi: 10.5173/ceju.2018.1740. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Progress in multidisciplinary treatment of Fournier's gangrene. Zhang KF, Shi CX, Chen SY, Wei W. Infect Drug Resist. 2022;15:6869–6880. doi: 10.2147/IDR.S390008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Dysregulated immunity and immunotherapy after sepsis. Darden DB, Kelly LS, Fenner BP, Moldawer LL, Mohr AM, Efron PA. J Clin Med. 2021;10:1742. doi: 10.3390/jcm10081742. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Exploration of different rehabilitation routes for sepsis survivors with monitoring of health status and quality of life: RehaSep trial protocol. Wójcik B, Superata J, Nguyen HB, Szyguła Z. Adv Ther. 2019;36:2968–2978. doi: 10.1007/s12325-019-01047-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Life after sepsis: an international survey of survivors to understand the post-sepsis syndrome. Huang CY, Daniels R, Lembo A, et al. Int J Qual Health Care. 2019;31:191–198. doi: 10.1093/intqhc/mzy137. [DOI] [PubMed] [Google Scholar]
- 8.Fournier's gangrene as special form of necrotizing fasciitis. Maier S, Eckmann C. Chirurg. 2020;91:307–312. doi: 10.1007/s00104-019-01095-5. [DOI] [PubMed] [Google Scholar]
- 9.Time is of the essence when treating necrotizing soft tissue infections: a systematic review and meta-analysis. Nawijn F, Smeeing DP, Houwert RM, Leenen LP, Hietbrink F. World J Emerg Surg. 2020;15:4. doi: 10.1186/s13017-019-0286-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Harmful molecular mechanisms in sepsis. Rittirsch D, Flierl MA, Ward PA. Nat Rev Immunol. 2008;8:776–787. doi: 10.1038/nri2402. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.The roles of early surgery and comorbid conditions on outcomes of severe necrotizing soft-tissue infections. Latifi R, Patel AS, Samson DJ, Tilley EH, Gashi S, Bergamaschi R, El-Menyar A. Eur J Trauma Emerg Surg. 2019;45:919–926. doi: 10.1007/s00068-018-0958-z. [DOI] [PubMed] [Google Scholar]
- 12.Necrotizing soft tissue infections: delayed surgical treatment is associated with increased number of surgical debridements and morbidity. Kobayashi L, Konstantinidis A, Shackelford S, Chan LS, Talving P, Inaba K, Demetriades D. J Trauma. 2011;71:1400–1405. doi: 10.1097/TA.0b013e31820db8fd. [DOI] [PubMed] [Google Scholar]
- 13.Risk factors for postoperative mortality and morbidities in emergency surgeries. Matsuyama T, Iranami H, Fujii K, Inoue M, Nakagawa R, Kawashima K. J Anesth. 2013;27:838–843. doi: 10.1007/s00540-013-1639-z. [DOI] [PubMed] [Google Scholar]
- 14.The complete blood count to diagnose septic shock. Farkas JD. J Thorac Dis. 2020;12:0–21. doi: 10.21037/jtd.2019.12.63. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Energetic dysfunction in sepsis: a narrative review. Preau S, Vodovar D, Jung B, et al. Ann Intensive Care. 2021;11:104. doi: 10.1186/s13613-021-00893-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.The effects of hyperbaric oxygenation on oxidative stress, inflammation and angiogenesis. De Wolde SD, Hulskes RH, Weenink RP, Hollmann MW, Van Hulst RA. Biomolecules. 2021;11:1210. doi: 10.3390/biom11081210. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Hyperbaric oxygen treatment is associated with a decrease in cytokine levels in patients with necrotizing soft-tissue infection. Hedetoft M, Garred P, Madsen MB, Hyldegaard O. Physiol Rep. 2021;9:0. doi: 10.14814/phy2.14757. [DOI] [PMC free article] [PubMed] [Google Scholar]